Reevaluating response and failure of medical treatment of endometriosis: a systematic review

Christian M Becker, William T Gattrell, Kerstin Gude, Sukhbir S Singh, Christian M Becker, William T Gattrell, Kerstin Gude, Sukhbir S Singh

Abstract

Objective: To assess patient response rates to medical therapies used to treat endometriosis-associated pain.

Design: A systematic review with the use of Medline and Embase.

Setting: Not applicable.

Patient(s): Women receiving medical therapy to treat endometriosis.

Interventions(s): None.

Main outcome measure(s): The proportions of patients who: experienced no reduction in endometriosis-associated pain symptoms; had pain symptoms remaining at the end of the treatment period; had pain recurrence after treatment cessation; experienced an increase or no change in disease score during the study; were satisfied with treatment; and discontinued therapy owing to adverse events or lack of efficacy. The change in pain symptom severity experienced during and after treatment, as measured on the visual analog scale, was also assessed.

Result(s): In total, 58 articles describing 125 treatment arms met the inclusion criteria. Data for the response of endometriosis-associated pain symptoms to treatment were presented in only 29 articles. The median proportions of women with no reduction in pain were 11%-19%; at the end of treatment, 5%-59% had pain remaining; and after follow-up, 17%-34% had experienced recurrence of pain symptoms after treatment cessation. After median study durations of 2-24 months, the median discontinuation rates due to adverse events or lack of efficacy were 5%-16%.

Conclusion(s): Few studies of medical therapies for endometriosis report outcomes that are relevant to patients, and many women gain only limited or intermittent benefit from treatment.

Keywords: Endometriosis; medical therapy; pain; systematic review.

Copyright © 2017. Published by Elsevier Inc.

Figures

Figure 1
Figure 1
PRISMA (Preferred Reporting Items of Systematic Reviews and Meta-Analyses) flow diagram of the literature search and article selection process. AE = adverse events.
Figure 2
Figure 2
Response to therapy and symptom recurrence after treatment cessation. Proportions of patients with (A) no reduction in pain symptoms, (B) pain symptoms remaining at end of treatment, and (C) recurrence of pain symptoms after treatment cessation. Results are presented as median (range). ND = no data; CHC = combined hormonal contraceptive.
Figure 3
Figure 3
Visual analog scale (VAS) scores for pain symptoms at baseline and during and after treatment for patients receiving medical therapy. Results are presented as median (range).

References

    1. Dunselman G.A., Vermeulen N., Becker C., Calhaz-Jorge C., d’Hooghe T., de Bie B. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:400–412.
    1. Giudice L.C. Clinical practice. Endometriosis. N Engl J Med. 2010;362:2389–2398.
    1. Crosignani P., Olive D., Bergqvist A., Luciano A. Advances in the management of endometriosis: an update for clinicians. Hum Reprod Update. 2006;12:179–189.
    1. Lee D.Y., Lee J.Y., Seo J.W., Yoon B.K., Choi D. Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis. Arch Gynecol Obstet. 2016
    1. Vercellini P., Somigliana E., Vigano P., Abbiati A., Daguati R., Crosignani P.G. Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol. 2008;22:275–306.
    1. Vercellini P., Vigano P., Somigliana E., Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10:261–275.
    1. Howard F.M. An evidence-based medicine approach to the treatment of endometriosis-associated chronic pelvic pain: placebo-controlled studies. J Am Assoc Gynecol Laparosc. 2000;7:477–488.
    1. Vercellini P., Cortesi I., Crosignani P.G. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril. 1997;68:393–401.
    1. Barbieri R.L., Evans S., Kistner R.W. Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up. Fertil Steril. 1982;37:737–746.
    1. Doberl A., Bergqvist A., Jeppsson S. Regression of endometriosis following shorter treatment with, or lower dose of danazol. Comparison of pre- and post-treatment laparoscopic findings in the Scandinavian multi-center study. Acta Obstet Gynecol Scand. 1984;63(Suppl 123):51–58.
    1. Miller J.D., Shaw R.W., Casper R.F.J., Rock J.A., Thomas E.J., Dmowski W.P. Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin-releasing hormone agonist. Fertil Steril. 1998;70:293–296.
    1. Bromham D.R., Booker M.W., Rose G.L., Wardle P.G., Newton J.R. A multicentre comparative study of gestrinone and danazol in the treatment of endometriosis. J Obstet Gynaecol. 1995;15:188–194.
    1. Bromham D.R., Booker M.W., Rose G.L., Wardle P.G., Newton J.R. Updating the clinical experience in endometriosis—the European perspective. Br J Obstet Gynaecol. 1995;102(Suppl 12):12–16.
    1. Halbe H.W., Nakamura M.S., Da Silveira G.P., Carvalho W.P. Updating the clinical experience in endometriosis—the Brazilian perspective. Br J Obstet Gynaecol. 1995;102:17–21.
    1. Carbonell J.L., Riveron A.M., Leonard Y., Gonzalez J., Heredia B., Sanchez C. Mifepristone 2.5, 5, 10 mg versus placebo in the treatment of endometriosis. J Reprod Health Med. 2016;2:17–25.
    1. Agarwal S.K., Hamrang C., Henzl M.R., Judd H.L. Nafarelin vs. leuprolide acetate depot for endometriosis: changes in bone mineral density and vasomotor symptoms. J Reprod Med. 1997;42:413–423.
    1. Ling F.W. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Pelvic Pain Study Group. Obstet Gynecol. 1999;93:51–58.
    1. Nafarelin European Endometriosis Trial Group Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up. Fertil Steril. 1992;57:514–522.
    1. Rolland R., van der Heijden P.F. Nafarelin versus danazol in the treatment of endometriosis. Am J Obstet Gynecol. 1990;162:586–588.
    1. Adamson G.D., Kwei L., Edgren R.A. Pain of endometriosis: effects of nafarelin and danazol therapy. Int J Fertil Menopausal Stud. 1994;39:215–217.
    1. Henzl M.R., Corson S.L., Moghissi K., Buttram V.C., Berqvist C., Jacobson J. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. N Engl J Med. 1988;318:485–489.
    1. Wheeler J.M., Knittle J.D., Miller J.D. Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results. Am J Obstet Gynecol. 1992;167:1367–1371.
    1. Shaw R.W. Zoladex Endometriosis Study Team. An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Fertil Steril. 1992;58:265–272.
    1. Rock J.A., Truglia J.A., Caplan R.J. Zoladex Endometriosis Study Group. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. Obstet Gynecol. 1993;82:198–205.
    1. Bergqvist A., Petersson F., Bergquist C., Elfgren K., Hahn L., Lalos O. A comparative study of the acceptability and effect of goserelin and nafarelin on endometriosis. Gynecol Endocrinol. 2000;14:425–432.
    1. Donnez J., Nisolle-Pochet M., Clerckx-Braun F., Sandow J., Casanas-Roux F. Administration of nasal buserelin as compared with subcutaneous buserelin implant for endometriosis. Fertil Steril. 1989;52:27–30.
    1. Hornstein M.D., Yuzpe A.A., Burry K.A., Heinrichs L.R., Buttram V.L., Jr., Orwoll E.S. Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain. Fertil Steril. 1995;63:955–962.
    1. Reichel R.P., Schweppe K.W., Zoladex Endometriosis Study Group Goserelin (Zoladex) depot in the treatment of endometriosis. Fertil Steril. 1992;57:1197–1202.
    1. Gokmen O., Ugur M. Treatment of endometriosis with Gn-Rh agonist triptorelin: a multicenter study. Turk J Med Sci. 1996;26:261–266.
    1. Zupi E., Marconi D., Sbracia M., Zullo F., de Vivo B., Exacustos C. Add-back therapy in the treatment of endometriosis-associated pain. Fertil Steril. 2004;82:1303–1308.
    1. Hornstein M.D., Surrey E.S., Weisberg G.W., Casino L.A. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Obstet Gynecol. 1998;91:16–24.
    1. Moghissi K.S., Schlaff W.D., Olive D.L., Skinner M.A., Yin H. Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis. Fertil Steril. 1998;69:1056–1062.
    1. Tsai H.W., Wang P.H., Huang B.S., Twu N.F., Yen M.S., Chen Y.J. Low-dose add-back therapy during postoperative GnRH agonist treatment. Taiwan J Obstet Gynecol. 2016;55:55–59.
    1. Strowitzki T., Marr J., Gerlinger C., Faustmann T., Seitz C. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod. 2010;25:633–641.
    1. Harrison R.F., Barry-Kinsella C. Efficacy of medroxyprogesterone treatment in infertile women with endometriosis: a prospective, randomized, placebo-controlled study. Fertil Steril. 2000;74:24–30.
    1. Crosignani P.G., Luciano A., Ray A., Bergqvist A. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod. 2006;21:248–256.
    1. Schlaff W.D., Carson S.A., Luciano A., Ross D., Bergqvist A. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril. 2006;85:314–325.
    1. Strowitzki T., Marr J., Gerlinger C., Faustmann T., Seitz C. Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis. Int J Gynaecol Obstet. 2012;117:228–233.
    1. Strowitzki T., Faustmann T., Gerlinger C., Seitz C. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2010;151:193–198.
    1. Petraglia F., Hornung D., Seitz C., Faustmann T., Gerlinger C., Luisi S. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet. 2012;285:167–173.
    1. Harada T., Momoeda M., Taketani Y., Aso T., Fukunaga M., Hagino H. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial. Fertil Steril. 2009;91:675–681.
    1. Luisi S., Parazzini F., Angioni S., Arena S., Berretta P., Candiani M. Dienogest treatment improves quality of life in women with endometriosis. J Endometriosis Pelvic Pain Disord. 2015;7:124–128.
    1. Leone Roberti Maggiore U., Remorgida V., Scala C., Tafi E., Venturini P.L., Ferrero S. Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study. Acta Obstet Gynecol Scand. 2014;93:239–247.
    1. Momoeda M., Harada T., Terakawa N., Aso T., Fukunaga M., Hagino H. Long-term use of dienogest for the treatment of endometriosis. J Obstet Gynaecol Res. 2009;35:1069–1076.
    1. Morotti M., Remorgida V., Venturini P.L., Ferrero S. Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura. Eur J Obstet Gynecol Reprod Biol. 2014;179:63–68.
    1. Vercellini P., Somigliana E., Consonni D., Frattaruolo M.P., de Giorgi O., Fedele L. Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I. Effect on pain during intercourse and patient satisfaction. Hum Reprod. 2012;27:3450–3459.
    1. Vercellini P., Bracco B., Mosconi P., Roberto A., Alberico D., Dhouha D. Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study. Fertil Steril. 2016;105:734–743.e3.
    1. Harada T., Momoeda M., Taketani Y., Hoshiai H., Terakawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2008;90:1583–1588.
    1. Vlahos N., Vlachos A., Triantafyllidou O., Vitoratos N., Creatsas G. Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study. Fertil Steril. 2013;100:1337–1342.
    1. Vercellini P., Barbara G., Somigliana E., Bianchi S., Abbiati A., Fedele L. Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis. Fertil Steril. 2010;93:2150–2161.
    1. Carr B., Dmowski W.P., O’Brien C., Jiang P., Burke J., Jimenez R. Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density. Reprod Sci. 2014;21:1341–1351.
    1. Diamond M.P., Carr B., Dmowski W.P., Koltun W., O’Brien C., Jiang P. Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study. Reprod Sci. 2014;21:363–371.
    1. Carr B., Giudice L., Dmowski W.P., O’Brien C., Jiang P., Burke J. Elagolix, an oral GnRH antagonist for endometriosis associated pain: a randomized controlled study. J Endometriosis. 2013;5:105–115.
    1. Alkatout I., Mettler L., Beteta C., Hedderich J., Jonat W., Schollmeyer T. Combined surgical and hormone therapy for endometriosis is the most effective treatment: prospective, randomized, controlled trial. J Minim Invasive Gynecol. 2013;20:473–481.
    1. Vercellini P., Crosignani P.G., Fadini R., Radici E., Belloni C., Sismondi P. A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol. 1999;106:672–677.
    1. Seracchioli R., Mabrouk M., Frasca C., Manuzzi L., Savelli L., Venturoli S. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertil Steril. 2010;94:464–471.
    1. Hornstein M.D., Hemmings R., Yuzpe A.A., LeRoy Heinrichs W. Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis. Fertil Steril. 1997;68:860–864.
    1. Seracchioli R., Mabrouk M., Frasca C., Manuzzi L., Montanari G., Keramyda A. Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial. Fertil Steril. 2010;93:52–56.
    1. Sesti F., Pietropolli A., Capozzolo T., Broccoli P., Pierangeli S., Bollea M.R. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III–IV. A randomized comparative trial. Fertil Steril. 2007;88:1541–1547.
    1. Roghaei M.A., Tehrany H.G., Taherian A., Koleini N. Effects of letrozole compared with danazol on patients with confirmed endometriosis: a randomized clinical trial. Int J Fertil Menopausal Stud. 2010;4:67–72.
    1. Gerhard I., Schindler A.E., Buhler K., Winkler U., Meinen K., Mancarella D. Treatment of endometriosis with leuprorelin acetate depot: a German multicentre study. Clin Ther. 1992;14(Suppl A):3–16.
    1. Szendei G., Hernadi Z., Devenyi N., Csapo Z. Is there any correlation between stages of endometriosis and severity of chronic pelvic pain? Possibilities of treatment. Gynecol Endocrinol. 2005;21:93–100.
    1. Bulletti C., Flamigni C., Polli V., Giacomucci E., Albonetti A., Negrini V. The efficacy of drugs in the management of endometriosis. J Am Assoc Gynecol Laparosc. 1996;3:495–501.
    1. Yang X.H., Ji F., AiLi A., TuerXun H., He Y., Ding Y. Effects of laparoscopic ovarian endometriosis cystectomy combined with postoperative GnRH-a therapy on ovarian reserve, pregnancy, and outcome recurrence. Clin Exp Obstet Gynecol. 2014;41:272–275.
    1. Kaser D.J., Missmer S.A., Berry K.F., Laufer M.R. Use of norethindrone acetate alone for postoperative suppression of endometriosis symptoms. J Pediatr Adolesc Gynecol. 2012;25:105–108.
    1. Lee D.Y., Bae D.S., Yoon B.K., Choi D. Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence. Hum Reprod. 2010;25:3050–3054.
    1. Gerlinger C., Schumacher S., Wentzeck R., Uhl-Hochgraber K., Solomayer E.F., Schmitz H. How can we measure endometriosis-associated pelvic pain? J Endometriosis. 2012;4:109–116.
    1. Acs N., O’Brien C., Jiang P., Burke J., Jimenez R., Garner E. Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist: results from a phase 2, randomized controlled study. J Endometriosis Pelvic Pain Disord. 2015;7:56–62.
    1. Henzl M.R., Kwei L. Efficacy and safety of nafarelin in the treatment of endometriosis. Am J Obstet Gynecol. 1990;162:570–574.
    1. de Graaff A.A., d’Hooghe T.M., Dunselman G.A., Dirksen C.D., Hummelshoj L., Simoens S. The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey. Hum Reprod. 2013;28:2677–2685.
    1. Casper R.F. Introduction: a focus on the medical management of endometriosis. Fertil Steril. 2017;107:521–522.
    1. Tracey I. Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat Med. 2010;16:1277–1283.
    1. Buchel C., Geuter S., Sprenger C., Eippert F. Placebo analgesia: a predictive coding perspective. Neuron. 2014;81:1223–1239.
    1. Vercellini P., Crosignani P.G., Somigliana E., Berlanda N., Barbara G., Fedele L. Medical treatment for rectovaginal endometriosis: what is the evidence? Hum Reprod. 2009;24:2504–2514.
    1. Fedele L., Bianchi S., Zanconato G., Portuese A., Raffaelli R. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril. 2001;75:485–488.
    1. Fedele L., Bianchi S., Zanconato G., Tozzi L., Raffaelli R. Gonadotropin-releasing hormone agonist treatment for endometriosis of the rectovaginal septum. Am J Obstet Gynecol. 2000;183:1462–1467.
    1. Vercellini P., Pietropaolo G., de Giorgi O., Pasin R., Chiodini A., Crosignani P.G. Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. Fertil Steril. 2005;84:1375–1387.
    1. Razzi S., Luisi S., Calonaci F., Altomare A., Bocchi C., Petraglia F. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Fertil Steril. 2007;88:789–794.
    1. Remorgida V., Abbamonte H.L., Ragni N., Fulcheri E., Ferrero S. Letrozole and norethisterone acetate in rectovaginal endometriosis. Fertil Steril. 2007;88:724–726.
    1. Hefler L.A., Grimm C., van Trotsenburg M., Nagele F. Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study. Fertil Steril. 2005;84:1033–1036.
    1. Sinaii N., Cleary S.D., Younes N., Ballweg M.L., Stratton P. Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience. Fertil Steril. 2007;87:1277–1286.
    1. Becker C.M., Laufer M.R., Stratton P., Hummelshoj L., Missmer S.A., Zondervan K.T. World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: I. Surgical phenotype data collection in endometriosis research. Fertil Steril. 2014;102:1213–1222.
    1. Vitonis A.F., Vincent K., Rahmioglu N., Fassbender A., Buck Louis G.M., Hummelshoj L. World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: II. Clinical and covariate phenotype data collection in endometriosis research. Fertil Steril. 2014;102:1223–1232.
    1. Chief Editors of Journals Participating in the CI The CROWN Initiative: journal editors invite researchers to develop core outcomes in women’s health. Khan K., editor. BJOG. 2016;123(Suppl 3):103–104.
    1. Bourdel N., Alves J., Pickering G., Ramilo I., Roman H., Canis M. Systematic review of endometriosis pain assessment: how to choose a scale? Hum Reprod Update. 2015;21:136–152.
    1. Vincent K., Kennedy S., Stratton P. Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials. Report from the Art and Science of Endometriosis meeting. Fertil Steril. 2010;93:62–67.
    1. Dworkin R.H., Turk D.C., Farrar J.T., Haythornthwaite J.A., Jensen M.P., Katz N.P. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113:9–19.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться